Aim and Scope

《中国心脏病学杂志》是一份同行评审的国际开放获取期刊，致力于在分子科学各个领域发表高质量的研究成果。我们的目标是为全球的研究人员、学者和专业人士提供一个可信赖的平台，分享新颖见解和突破性发现，推动医学、材料科学及生物医学科学的发展。
我们坚持科学卓越，倡导伦理研究实践，并促进国际合作。通过开放获取的出版模式，我们确保创新研究能够被更广泛的受众获取，提高其可见度与影响力，从而在全球科学界产生更大的影响.
《中国心脏病学杂志》的主要目标是鼓励和支持前沿研究，以推动人类健康、疾病、药物开发、分子机制及生物医学技术方面的理解与进步。我们欢迎在分子科学领域具有科学创新价值的原创研究文章、系统综述、病例报告、简讯以及临床研究的投稿。
本刊欢迎来自分子与生物医学科学多学科领域的科学家、医疗专业人员、学者以及行业专家的投稿。所有稿件均需经过严格的同行评审程序，以确保发表的研究具有高质量、符合伦理规范，并具有重要影响力。

期刊涵盖领域
《中国心脏病学杂志》发表涵盖多个学科的研究内容，包括但不限于:
● 心血管病理生理与机制 – 研究心血管疾病的分子和细胞机制及治疗靶点.
● 临床心脏病学 – 包括高血压、心力衰竭和心律失常等心血管疾病的诊断、治疗和管理.
● 介入性心脏病学 – 关于血管成形术、支架植入、导管介入治疗和心血管影像技术的研究.
● 电生理与心律失常 – 包括心脏电生理、心律失常机制以及起搏和除颤治疗.
● 心脏影像学 – 超声心动图、心脏磁共振成像（MRI）、CT冠状动脉造影和核医学心脏病学的新技术与进展.
● 预防性心脏病学与危险因素 – 关于脂质代谢、糖尿病、吸烟以及生活方式干预在降低心血管风险方面的研究.
● 小儿心脏病与先天性心脏病 – 婴幼儿和儿童心脏疾病的研究，包括先天性异常及其手术结果.
● 心血管药理学 – 有关心血管药物、药物相互作用以及治疗效果的研究。
● 心脏外科与植入设备 – 心脏外科技术、人工瓣膜、辅助装置和心脏移植方面的最新进展。
● 心血管遗传学与精准医学 – 探讨心血管疾病的遗传基础和个体化治疗方法。

通过发表高影响力、创新性和多学科的研究，《分子科学杂志》旨在弥合分子研究与实际应用之间的差距，促进生物医学和材料科学的新发展。

Chinese Journal of Cardiology is a peer-reviewed, international, open-access journal committed to publishing high-quality research in all aspects of molecular sciences. Our objective is to serve as a trusted global platform for researchers, academicians, and professionals to share novel insights and groundbreaking discoveries that contribute to scientific advancements in medical, Materials Sciences, and biomedical sciences.

We are dedicated to maintaining scientific excellence, promoting ethical research practices, and fostering international collaboration. Through our open-access model, we ensure that innovative research reaches a broad audience, enabling wider dissemination, greater visibility, and a higher impact on the global scientific community.

Aim & Scope

The primary aim of the Chinese Journal of Cardiology is to encourage and support cutting-edge research that advances our understanding of human health, diseases, drug development, molecular mechanisms, and biomedical technologies. We welcome original research articles, systematic reviews, case reports, short communications, and clinical studies that contribute to scientific progress and innovation in molecular sciences.

Our journal seeks contributions from scientists, healthcare professionals, academicians, and industry experts working in multidisciplinary domains of molecular and biomedical sciences. Every submission undergoes a rigorous peer-review process to ensure the publication of high-quality, ethically sound, and impactful research.

Areas Covered by the Journal

The Chinese Journal of Cardiology publishes research across a wide range of disciplines, including but not limited to:

• Cardiovascular Pathophysiology & Mechanisms – Disease pathogenesis, molecular diagnostics, and targeted therapies.
• Clinical Cardiologyy – Drug design, molecular pharmacology, toxicology, and drug interactions.
• Interventional Cardiology – Genomic studies, gene therapy, CRISPR technology, and genetic disorders.
• Electrophysiology & Arrhythmia – Protein engineering, enzyme mechanisms, and molecular interactions.
• Cardiac Imaging – Immune system modulation, vaccine development, and microbial pathogenesis.
• Preventive Cardiology & Risk Factors – Neurodegenerative diseases, cognitive research, and neural therapies.
• Pediatric Cardiology & Congenital Heart Disease – Stem cell applications, tissue engineering, and gene editing.
• Cardiovascular Pharmacology – Genomics, proteomics, computational biology, and AI in healthcare.
• Cardiac Surgery & Devices – Disease surveillance, epidemiological studies, and health policy research.
• Cardiovascular Genetics & Precision Medicine – MRI, CT scans, molecular imaging, and diagnostic advancements.
By publishing high-impact, innovative, and multidisciplinary research, the Chinese Journal of Cardiology aims to bridge the gap between molecular research and real-world applications, fostering new developments in biomedical and Material sciences.